Research Article
Role of HLA-B Alleles and Clinical Presentation of B27 Negative Spondyloarthritis Patients from Mumbai, Western India
Table 1
Distribution of HLA-B alleles among B27 negative SpA patients and controls from Western India (patients (
); controls (
)).
| Serial number | HLA-B |
%PF
| %P.F | OR | 95% CI | Y | value |
| 1 | B*51 | 10 | 13 | 0.743 | 0.309–1.785 | 0.196 | 0.506 | 2 | B*52 | 7 | 8 | 0.865 | 0.301–2.485 | 0.072 | 0.788 | 3 | B*07 | 54 | 18 | 5.348 | 2.808–10.186 | 26.584 | 1.14E − 07 | 4 | B*15 | 19 | 12 | 1.720 | 0.785–3.765 | 1.374 | 0.171 | 5 | B*08 | 12 | 14 | 0.837 | 0.366–1.914 | 0.044 | 0.674 | 6 | B*18 | 6 | 9 | 0.645 | 0.220–1.887 | 0.288 | 0.420 | 7 | B*13 | 4 | 3 | 1.347 | 0.293–6.183 | 0.148 | 0.700 | 8 | B*40 | 17 | 32 | 0.435 | 0.222–0.850 | 5.298 | 0.013 | 9 | B*35 | 33 | 44 | 0.626 | 0.353–1.113 | 2.112 | 0.109 | 10 | B*57 | 9 | 7 | 1.314 | 0.469–3.678 | 0.067 | 0.602 | 11 | B*58 | 8 | 4 | 2.080 | 0.607–7.169 | 0.797 | 0.233 | 12 | B*44 | 9 | 15 | 0.560 | 0.232–1.348 | 1.184 | 0.191 | 13 | B*47 | 3 | 6 | 0.484 | 0.117–1.995 | 0.465 | 0.306 | 14 | B*48 | 2 | 0 | 5.102 | 0.241–107.70 | 0.505 | 0.155 | 15 | B*53 | 1 | 1 | 1.000 | 0.061–16.224 | 0.000 | 1.000 | 16 | B*49 | 1 | 3 | 0.326 | 0.033–3.196 | 0.255 | 0.312 | 17 | B*38 | 0 | 1 | 0.330 | 0.013–8.205 | 1.005 | 0.316 | 18 | B*78 | 0 | 2 | 0.196 | 0.009–4.138 | 0.505 | 0.155 | 19 | B*81 | 1 | 3 | 0.326 | 0.333–3.196 | 0.255 | 0.312 | 20 | B*37 | 1 | 3 | 0.326 | 0.333–3.196 | 0.255 | 0.312 | 21 | B*42 | 0 | 1 | 0.330 | 0.013–8.205 | 1.005 | 0.316 | 22 | B*56 | 3 | 1 | 3.062 | 0.312–29.965 | 0.255 | 0.312 |
|
|
N+: number positive, PF: phenotype frequency, OR: odds ratio,
Y: chi-square with Yates’ correction.
|